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ABSTRACT 
 
 
 
 
 Mutations in the highly conserved zinc-binding domain of the β’ subunit of E.coli 
RNA polymerase prevent the growth of phage that use a unique RNA-based mechanism 
of transcription antitermination. Here, we describe the isolation and characterization of a 
mutant phage that overcomes this block. The genome of the mutant only differs from the 
parental phage by 2 nucleotides. Close inspection of the sequences surrounding the 
mutation suggested that a new promoter had been created. This was confirmed by cloning 
the potential promoter sequences into a promoter probe expression vector. We 
hypothesize that the new promoter permits the expression of phage genes that are 
essential for growth on the mutant bacterial host.  
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Gene expression is the process by which DNA information is transformed into 
functional products, such as proteins. The model that summarizes this process is known 
as the Central Dogma: DNA is transcribed to mRNA and mRNA is translated into protein 
[1]. Gene expression is a highly regulated event and regulation often occurs at the 
transcriptional level. The enzyme responsible for all transcription is RNA polymerase. 
Proper functioning RNA polymerase is essential for cell viability [2].  
 For viruses, whose survival depends on the utilization of the host’s replication, 
transcription, and translation machinery, it is especially important that RNA polymerase 
functions properly. Because of this dependence, viruses can be used as a model to 
understand how mutations in RNA polymerase affect its function [2].  
Viruses that infect bacteria are called bacteriophages or phage. Temperate phages 
can adopt two different life cycles:  lysogenic or lytic. The phage life cycles have been 
extensively studied in order to understand viral growth properties, gene expression and 
virus-host interactions. [2] 
The Lytic Cycle 
Phage infection begins when it attaches to host cell surface receptors.  The 
genomic material is then injected into the host cell cytoplasm. Upon successful entry, the 
DNA circularizes and phage gene expression begins. Phage genes are expressed in a
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specific order to ensure that key components of the phage are produced as needed. Once 
the phage has generated all of its structural components, the DNA is packaged and the 
particles are assembled. At the end of the infection cycle, lysin, an enzyme that directs 
cell lysis, is made. This enzyme causes degradation of the cell wall, which weakens it, 
allowing it to succumb to osmotic pressure and resulting in cell lysis. New phage 
particles erupt from the cell to continue to the cycle by infecting other bacterial hosts. [2] 
See Figure 1.  
Lysogenic Cycle 
 The lysogenic cycle is begins similarly to the lytic cycle. The phage attaches to 
the bacterial cell and injects its DNA into the host. However after injection and 
circularization of the phage DNA, the phage genome is integrated into the host 
chromosome and becomes a “prophage”.  Due to the activity of the phage repressor 
protein, most phage genes are not expressed in the prophage. The phage can exist in this 
stage through multiple cellular replications. A prophage can become a lytic phage either 
spontaneously or in response to a stimulus such as DNA damage. This causes the phage 
genome to excise and enter the lytic cycle. See Figure 1. 
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Figure 1. Lytic vs. Lysogenic cycles. Part A shows the initial encounter between a phage and a host bacterium. Part B 
shows the attachment by the phage and injection of its DNA. Part C. The phage DNA circularizes. Parts D and E show 
the replication of the phage inside the cell and rupture of the cell in the lytic cycle. Parts F and G show the insertion of 
the phage DNA into the chromosome and continual replication of the bacterial chromosome with the prophage. The red 
represents bacteria chromosomal DNA while the green represents phage DNA. [3] 
Gene Expression 
 As previously mentioned, gene expression is the process by which information 
found in DNA is transformed into products such as RNA and proteins. It is the expression 
of these genes that give rise to the phenotype of the organism. This occurs in two general 
steps: transcription (the process of copying DNA into RNA) and translation (the process 
of making proteins from the RNA message). [2] 
Transcription 
 Bacterial transcription begins when RNA polymerase binds to the DNA at 
a promoter sequence. E.coli RNA polymerase is comprised of five subunits to recognize 
components of a promoter: , ’, 2 α, and ω subunits (Shown in Figure 2; ω is not 
pictured). An additional subunit called  gives RNA polymerase its sequence specificity 
by recognizing the promoter consensus sequence, which is the most commonly 
recognized sequence for that promoter. There are many  factors that recognize different 
consensus sequences. The σ70 subunit confers sequence specificity to the RNA 
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polymerase by recognizing a TTGACA hexameric sequence at the -35 region and 
TATAAT hexameric sequence at the -10 region relative to the start of transcription 
(designated  +1).  [4, 5] 
 
 
Figure 2.  E.coli RNA Polymerase bound to a bacterial promoter. The RNA polymerase is represented in red and 
different subunits are labeled. The orange represents the sigma-70 factor that recognizes the promoter. The direction of 
transcription is indicated along with the -35, -10, and +1 regions. [2, 6] 
Promoters can vary in strength depending on how closely they match the 
consensus promoter sequence and the distance between the -35 and -10 elements. The 
optimal distance is 17 base pairs. Deviation from the consensus spacing typically results 
in a weaker promoter. [4, 5] Sequences such as an UP element can compensate for 
nonconsensus promoter sequences.  
UP element 
An UP element is a sequence found upstream of the -35 region in some bacterial 
promoters. This sequence increases transcription by interacting with the α subunit of 
polymerase. The standard consensus sequence of an UP element is shown in Figure 3 [7].  
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Figure 3. UP Element consensus sequence. The bottom line shows the UP element consensus sequence. The top shows 
the frequency of nucleotides occurring at each position in the UP element sequence; taller nucleotides correspond to an 
increased frequency of occurrence. [7] 
 The UP element sequence is typically located between -59 and -38 relative to the 
start site of transcription. Published experiments have shown that presence of an UP 
element sequence can increase transcription by as much as 326-fold. The size of the letter 
in the top row of Figure 3 indicates the frequency of the nucleotide occurring in the UP 
element sequence. The bottom row is a consensus sequence for UP elements, with the 
most common nucleotides indicated.  Positions marked with an “n” can be any 
nucleotide. Eleven matches out of 15 are sufficient to confer activity. [7] 
Termination 
 Transcription terminators are sites that cause the RNA polymerase to stop 
transcribing. At these sites, the newly formed RNA is released and enzyme dissociates 
from the DNA. E.coli transcription terminators are divided in to two categories: rho-
independent (or intrinsic) and rho-dependent. [2] 
Rho-Independent Termination 
Intrinsic terminators do not require additional proteins to assist in the termination 
process, but they do require structured RNA. These terminators contain a region that is 
rich in G-C bases that will allow it to fold upon itself into a structure called a hairpin, due 
to base complementarity. In addition to the hairpin, the RNA must also contain a region 
of seven to nine consecutive uracil residues at the base of the hairpin. Biochemical 
evidence has shown that the hairpin causes RNA polymerase to pause. This is thought to 
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provide time for the weak uracil bonds in the U-rich region of the transcript to 
disassociate from the DNA template and terminate transcription. Approximately half of 
all E.coli genes have intrinsic terminators at their 3’ end, especially those found in 
operons. [2] Figure 4 illustrates the general features of an intrinsic terminator.  
 
Figure 4.  Rho-independent terminator. The hairpin loop forms as a result of complementary base pair interactions in 
the G-C rich regions of the transcript. This structural feature interacts with RNA polymerase, shown faintly in purple, 
causing it to slow. The U-rich region, composed of weakly interacting uracil bases, dissociates from the DNA leading 
to transcription termination. [8] 
Rho-dependent Termination 
 Rho-dependent termination requires the activity of a protein called “Rho”. This 
factor is found in E.coli and catalyzes transcription termination at rho-dependent 
terminators. Rho binds to the rut (rho utilization) site in the RNA transcript, which is a C-
rich region approximately 70 bases long. It then moves along the RNA until it catches up 
with the stalled RNAP molecule. Once Rho catches up to the polymerase, its helicase 
activity dissociates the RNA-DNA hybrid and the transcript is released [2]. Figure 5 
illustrates the events that occur during rho-dependent termination. 
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Figure 5. Mechanism of Rho-dependent transcription termination. RNA Polymerase binds promoter on the DNA and 
initiates transcription (A). The Rho protein (red) binds at the rut site on the mRNA (B), it then moves along the mRNA 
until it reaches the stalled polymerase (C), and causes dissociation of the ternary complex (D).  [9] 
Antitermination 
  Transcription antitermination was first discovered in experiments performed with 
bacteriophages and led to the discovery of phage-encoded antitermination proteins that 
promoted terminator read through. In this process, the final RNA product is elongated 
because polymerase is modified to ignore the terminator and continue transcription. The 
first antitermination mechanism was discovered in the phage Lambda. 
Lambda phage 
Two proteins mediate antitermination in bacteriophage Lambda: N and Q. The N 
protein binds to a specific 15-nucleotide RNA element called boxB, which is encoded at 
two different locations on the Lambda genome. One is located near the starting point of 
the PL operon and the other is located after the first translated gene of the PR operon. [10] 
The boxB sequence is located adjacent to a second critical sequence called boxA. These 
sequences constitute the N utilization site, or nut site. Binding of the N protein to the nut 
site in RNA, is stabilized by several host-encoded proteins called the Nus factors. This 
complex of proteins converts RNAP into a termination resistant form. [10]  
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The Q protein is responsible for antiterminating late gene expression that initiates 
at the late gene promoter PR
’
. Q is a DNA binding protein that specifically recognizes the 
qut site located just downstream of PR’. Q interacts with a stalled RNA polymerase and 
stabilizes the elongation complex. [10, 11] Figure 6 shows a simplified mechanism for 
antitermination. 
 
Figure 6. Antitermination of transcription. The top half of the figure shows the normal progression of a termination 
event that results in the disassociation of the RNA polymerase (purple), from the DNA and the release of the transcript. 
The bottom half shows the antitermination protein in green interacting with the enzyme to allow transcription to 
continue into downstream genes allowing extension of the original nascent mRNA transcript. [12] 
Bacteriophage HK022  
HK022 is a lambdoid phage that antiterminates early gene expression in an 
unusual way.  It does not encode an N-like antitermination protein. Instead, it promotes 
antitermination directly through the action of RNA molecules called   put (polymerase 
utilization) sites. This type of antitermination is called factor-independent 
antitermination. [10] After the put regions are transcribed, they fold into a structure that 
contains two stem and loops separated by an unpaired base. (Figure 7) The folded RNA 
interacts with RNA polymerase to make it highly processive and termination resistant [7]. 
HK022 antiterminates late gene expression using a Q-protein dependent mechanism 
similar to that of the Lambda phage. [10] 
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Figure 7. RNA stem-loop structures of HK022 putL and putR [13]. 
Lambda and HK022 suppress both categories of terminators found in E. coli. This 
suggests the mechanisms of intrinsic and Rho-dependent terminators share common 
steps. Antitermination may be achieved by preventing destabilization of the RNA-DNA 
hybrid and/or accelerating RNA polymerase past termination sites [10]. 
A Host Mutation that Blocks Antitermination 
 The ’ subunit of RNA Polymerase is encoded by the rpoC gene. Mutations in 
this gene that block HK022 growth change amino acid residues in the highly conserved 
zinc-binding region (Figure 8). [14] These mutations block HK022 growth by preventing 
the interaction of the put sites with RNA polymerase [14]. 
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Figure 8. Mutations in the ’ subunit of RNA Polymerase that prevent HK022 antitermination. Diagram of cysteine 
cluster that binds zinc in the ’ subunit. The arrows indicate the changes to the amino acids, which are number 
according to their appearance in the protein sequence [14]. 
Reporter Vectors 
Plasmids are small, circular, self-replicating, extra-chromosomal DNAs. Although 
they are nonessential, they often contain genes that provide special capabilities to a cell, 
such as antibiotic resistance. Plasmids are a critical tool in molecular biology. [2] 
Reporter vectors are plasmids that are useful for identifying promoters. These vectors 
contain selectable markers and unique restriction sites for DNA insertion. Selectable 
markers are genes that allow for selection of transformed cells, such as antibiotic 
resistance. In a promoter probe vector, the reporter gene will only be expressed if the 
inserted DNA contains promoter activity and thus provides a way to quantify the activity 
of the promoter [2]. 
The reporter vector used in this study was the pRS415 plasmid. This vector 
contains the lacZ reporter gene and the Ampicillin resistance gene used for selection. The 
plasmid has four tandem copies of the T1 terminator, upstream of the multiple cloning 
site (MCS) [15]. These serve to block transcription originating from upstream promoters. 
The MCS contains EcoR1, BamH1, and Sma1 restriction sites, which can be used to 
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clone DNA fragments that are suspected to contain promoter sequences [15]. The 
reporter gene is the lacZ gene and does not contain a promoter. The lacY and lacA are 
also part of the lac operon, where lacY encodes for permease, which is a molecule that 
brings lactose into the cell, and lacA encodes for an enzyme that transfers an acetyl group 
from acetyl-CoA to -galactoside [15]. These genes are necessary for lactose catabolism 
[16]. Figure 9 illustrates important features of the pRS415 plasmid.   
 
Figure 9.  pRS415 plasmid. The lacZ reporter gene and the ampicillin resistance, Ampr, gene are labeled. The MCS 
region (gray) contains unique EcoR1, BamH1, and Sma1 restriction sites. The series of four strong terminators, T1, is 
denoted in orange [15, 17].  
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CHAPTER 2 
 
 
MATERIALS AND METHODS 
 
 
Bacteria and Phages used in this Study 
E.coli strain MC1000 is the bacterial strain used in electroporation. This strain 
contains the (lac)X74 mutation, which makes it in defective in the metabolism of 
lactose [18]. Bacteriophage O276 originates from the study by Oberto, et. al [19] and 
contains the Lambda b519 and b515 deletions with the HK022 genes nun, cI, cro and cII. 
Bacteriophage O367 is a derivative of O276 and originates from this work.  
Plasmid 
 The pRS415 reporter plasmid shown in Figure 9 was used to quantify promoter 
strength.  
Plasmid DNA Isolation 
Cells containing the pRS415 plasmid were grown in 125ml of TB (Appendix A) 
in an Erlenmeyer flask at 37°C with shaking (250 rpm) for 24 hours before isolation. 
Two 50ml aliquots were each placed into a 50ml culture tube (Fisherbrand Cat. No. 06-
443-18) and centrifuged at 15500xg for 15 minutes at 4°C to pellet the cells. For DNA 
isolation, the protocol from the Qiagen Qiafilter Plasmid Midi Kit (Cat. No. 1243) was 
followed. The final volume for the plasmid preparation was 50μl. A NanoDrop 
Spectrometer was used to determine the purity and concentration of the sample.  
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To recover plasmids from the various clones of pRS415 made in this study, the 
QIAGEN QIAprep Spin Mini Prep Kit was used as recommended by the manufacturer 
(Cat. No. 27104). 
Preparing the pRS415 vector for cloning 
Restriction enzyme reactions for preparing the pRS415 vector for cloning DNA 
sequences amplified from phages O276 and O367 are shown in Table 1.  
Table 1. Restriction Digest Reaction Volumes 
BamH1 EcoR1 
20l DNA 
(780.2ng/l) 
20l DNA 
(780.2ng/l) 
5l Buffer #3 
(New England BioLabs; 10X 
Concentration; #B7003S) 
5l EcoR1 Buffer  
(New England BioLabs; 10X 
Concentration; #B0101S) 
20l nanopure H2O 24l nanopure H2O 
3l BSA buffer 
(New England BioLabs; 10mg/ml; 
#B9001S) 
 
2l Enzyme 
(New England BioLabs; 20000 u/ml; 
#R0136S) 
1l Enzyme 
(New England BioLabs; 20000 u/ml; 
#R0101S) 
Total reaction volume: 50l Total reaction volume: 50l 
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Digests were incubated at 37C for 2-2.5 hours. A 5μl aliquot of each digest was 
analyzed by gel electrophoresis to ensure proper cutting. The expected fragment size was 
10,746 base pairs. 
To generate both cloning sites in the pRS415 vector, the digests were first purified 
using the chloroform-phenol extraction method to remove the enzyme and the buffer 
solution.  After purification, the DNA was digested with the opposite enzyme. The 
double digested vector was analyzed for complete digestion via gel electrophoresis. 
Double digested vectors were further purified by gel purification and the phenol/freeze 
method [21]. 
Restriction Digest of PCR Amplified Phage DNA 
Phage PCR products were double digested with EcoR1 and BamH1in a single 
reaction.  A typical 50 l reaction consisted of the following: 
30 l of DNA (456-2061 ng) 
7μl of EcoR1 buffer (New England BioLabs; 10X Concentration; #B0101S) 
2μl of BSA buffer (New England BioLabs; 10mg/ml; #B9001S) 
9μl of H2O 
1μl of EcoR1 enzyme (New England BioLabs; 20,000 u/ml; #R0101S) 
1μl of BamHI enzyme (New England BioLabs; 20,000 u/ml; #R0136S) 
50μl Total reaction volume 
These reactions were incubated at 37C for 2-2.5 hours and purified using the 
Qiagen QIAquick PCR Purification Kit (Cat. No. 28104) according to the manufacturer’s 
instructions.  
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Agarose Gel Electrophoresis 
Gel electrophoresis was used to separate DNA molecules based on differences in 
size. Agarose (Fisher BioReagents: BP160-100) is a linear polymer of - and -
glycosidic linkages of alternating resides of D- and L-galactose and is derived from a 
species of seaweed. [20] 
Agarose gel provides a matrix through which DNA molecules can pass and be 
differentially separated based upon their length.  Movement of the DNA is due to the 
electrical current that is passed through the gel. DNA moves from the negatively charged 
pole to the positively charged pole because of DNA’s overall negative charge. The size of 
the DNA fragment and the porosity of the gel affect the speed at which DNA moves 
through the gel. A higher concentration of agarose achieves better resolution of small 
DNA fragments, and lower concentrations of agarose allow for better resolution of larger 
fragments. Additionally, the applied voltage also affects the resolution of DNA 
fragments. [20] 
Preparation of agarose gels  
Agarose solutions used in this study were made by dissolving 1.2 grams of 
agarose in 100ml of 1X TAE buffer (Tris-base, acetic, acid, EDTA buffer; Appendix A). 
After boiling the solution, the molten agarose was cooled to 55C before pouring 30ml 
into a gel mold. A comb was used to create the wells for sample loading. After cooling, 
the comb was removed from the hardened agarose and the gel was placed into an 
electrophoresis tank and submerged in 1X TAE buffer. Electrophoresis was carried out at 
90V for 1 hour. Agarose gels with a higher concentration were run for 75 minutes. 
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Before being loaded into the wells of an agarose gel, DNA samples were first 
mixed with a loading dye (Appendix A).  This dye facilitates sample loading in two 
ways. The color makes it easier to see the sample as it is pipetted into the wells of the 
translucent gel.  It also contains glycerol, which increases the density of the sample. This 
ensures that the sample sinks into the well as it is being loaded. DNA ladders containing 
fragments of known size were included on all gels. The markers used in this study 
included the Lambda HindIII ladder (Fermentas; 0.5 mg/ml; #SM0101) and the 100 base 
pair ladder (Axygen Product No. M-DNA-100bp 500 l)  
Visualization of DNA in agarose gels 
After electrophoresis, agarose gels were stained with ethidium bromide (0.5 
g/ml final concentration in 1X TAE buffer; Sigma-Aldrich 10 mg/ml stock; E1510-10 
ml) for 10 minutes. The ethidium bromide inserts into the DNA and fluoresces when 
exposed to UV light. Photodocumentation was done with Alpha Innotech FluorChem 
HD2 (S/N: 504332; EPI UV Lights: Dual 254/365nm). 
Purification of Plasmids after Digestion 
Proteins were removed from the restriction digests using chloroform-phenol 
extraction (Chloroform: Fisher Chemical, C298500; Phenol: Fisher BioReagents. 
BP1750’-100). Briefly, an equal volume of chloroform and phenol were mixed in a 
microcentrifuge tube (total volume = 1ml). To facilitate pipetting, the restriction digest 
volumes were increased to 100μl with the DNA elution buffer (EB; QIAGEN; Mat. No. 
1014608). An equal volume of the chloroform-phenol mixture was then added and 
vortexed until the solution turned milky white.  The mixture was then centrifuged at 
12000xg for ~15-20 seconds at room temperature. The aqueous (top) layer, which 
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contained the DNA, was transferred to a fresh microcentrifuge tube. The organic phase 
was back extracted once with 100μl of EB buffer to recover any remaining DNA and the 
aqueous phase was combined with the first extraction. The combined aqueous sample 
was extracted with an equal volume of phenol/chloroform twice more. Three extractions 
with an equal volume of chloroform were performed to remove any traces of phenol. The 
chloroform was removed by ultrafiltration.  
Ultrafiltration 
Buffer exchanges were accomplished using Amicon Ultra Centrifugal Filter Units 
(0.5ml; UFC 510096). A sample was placed into a filtration unit and diluted with 
nanopure H2O (total unit volume = 500 l). The sample was centrifuged at 6600xg for 10 
minutes at room temperature in the microcentrifuge. The flow through was discarded.  
The filter cup was refilled with 500μl of nanopure H2O and the centrifugation was 
repeated. The flow through was again discarded. The filter unit was then transferred to a 
fresh collection tube.  A small amount (20μl) of nanopure H2O was typically used to 
wash the filter surface before sample recovery.  The sample was recovered from the unit 
by placing the inverted filter cup in a collection tube then centrifuging at 6600xg for 3 
minutes. The final recovered volume was approximately 40μl.  
For ligation reactions, the entire 20μl heat inactivated reaction was transferred to a 
filter unit. To maximize recovery of the ligation products, the reaction tube was washed 
with 80μl of nanopure H2O, and this volume was added to the filter cup. Nanopure water 
was added (final volume = 500l) and filtration was carried out as outlined above. For 
sample recovery, no additional water was added. In this case, the final recovered volume 
was approximately 20μl.  
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Gel Purification of DNA 
Specific DNA fragments were recovered from agarose gels using the 
phenol/freeze method [21]. After electrophoresis and staining, the gels were placed on 
UV light box. Upon illumination, the desired DNA bands were cut from the gels using a 
razor blade. This was done as quickly as possible to minimize exposing the DNA to UV 
light. The gel slice was cut in half and placed into separate 1.5 microcentrifuge tubes. 
These larger pieces of gel were then minced with a needle to increase the surface area. 
Eight hundred μl of phenol was added and the mixture was vortexed thoroughly. The 
tubes were then incubated for 10 minutes at -80°C. The frozen samples were then 
centrifuged at 12000xg at room temperature for 10 minutes to separate the agarose and 
phenol from the aqueous layer. The aqueous (top layer), containing the DNA, was 
pipetted into a fresh tube and extracted three times with an equal volume of chloroform to 
remove any traces of phenol. The aqueous layer was then transferred to a fresh 
microcentrifuge tube and the DNA was recovered by ethanol precipitation.  
Concentration of DNA by Ethanol Precipitation 
Ethanol precipitation was used to concentrate DNA samples and remove residual 
agarose after the gel purification process. A 1/10
th
 volume of 3M Sodium acetate (pH 
5.2) was added to the DNA containing solution and mixed well.  This was followed by 
the addition of two volumes of cold ethanol. After mixing, the samples were stored 
overnight at -20C.  
After overnight storage, the solution was centrifuged for 15 minutes at 16000xg at 
4C. The supernatant was removed quickly by inversion. The tubes were kept in an 
inverted position while the alcohol was allowed to evaporate. The precipitated DNA was 
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resuspended in 100μl of EB buffer and transferred to an Amicon Centrifugal Filtration 
device. The tube that contained the precipitate was washed with an additional 100μl of 
EB buffer and this was combined with the sample in the filter cup. Three hundred ls of 
nanopure H2O was added to the filter cup (total volume 500l) and the samples were 
centrifuged as outlined in “Ultrafiltration”. Washings with nanopure H2O were repeated 
twice before the concentrated sample was recovered.  The final volume of the DNA 
solution was 50μl in nanopure H2O. Five ls of this purified sample was analyzed by gel 
electrophoresis.  
PCR  
Amplification of Phage DNA 
PCR was used to specifically amplify the region of DNA suspected to contain a 
new promoter. Four primer pair combinations were designed to amplify the desired 
regions from the parental and mutant phages. Table 2 contains the list of the primers. 
Table 3 contains the strain numbers assigned to the amplified segments of DNA with the 
expected fragment size. 
Table 2. Primers 
PRIMER SEQUENCE 
RK765 GATCGAATTCATCCCAAAAGAATCTGACG 
RK767 GATCGGATCCGACGTCTTAGCCACCG 
RK770 GATCGGATCCGCACGAGATACATGGTAAG 
RK1 GTTTTCCCAGTCACGAC 
*EcoR1 (GAATTC) and BamHI (GGATCC) restriction enzyme cut sites underlined. 
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Table 3. Amplicon Strains and Sizes 
Primer pair Strain Number Fragment Size 
RK765 x RK770 1362 (parental*) 
1364 (mutant*) 
567 base pairs 
RK765 x RK767 1359 (parental*) 
1360 (mutant*) 
74 base pairs 
*indicates the DNA used as template 
A master mix solution was created to set up multiple PCR reactions quickly and 
accurately. Master mixes included: 
 1.5l primer 1 (100pmol/μl) 
 1.5μl primer 2 (100pmol/l) 
 45μl PCR mix (Buffer A, dNTPs; Appendix A) 
 0.75μl Taq enzyme (Fisher Scientific; 5000 u/ml; FB600015) 
 96.75μl nanopure H2O 
 145.5μl for 3 tubes total volume 
 48.5μl volume per tube 
See Table 4 for thermocycling settings.  
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Table 4: Polymerase Chain Reaction Thermal Cycler Settings 
 Temperature (C) Time (Minutes) 
Step 1 94 2:00 
Step 2 94 0:30 
Step 3 55 0:30 
Step 4 72 1:00 
Step 5 Go to step 2 and repeat cycle 30 times 
Step 6 4 Forever 
Step 7 End 
 
Amplicons were examined by gel electrophoresis prior to purification to ensure 
successful amplification of the desired products. PCR reactions were purified using the 
column-based Qiagen QIAquick PCR Purification Kit (Cat. No. 28104) according to the 
manufacturer’s instructions. The recovered volume was 50 l in nanopure H2O. After 
purification, the samples were analyzed on a NanoDrop Spectrophotometer to determine 
concentration. 
Whole Cell PCR  
Whole cell PCR was conducted on clone cultures containing the proper plasmids 
with the correct fragment insert. A larger volume of cells was used in this reaction than 
the template DNA used previously to ensure an adequate amount of DNA was present for 
amplification. A typical reaction consisted of the following: 
 0.5μl primer 1 (100pmol/l) 
 0.5μl primer 2 (100pmol/l) 
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 15μl PCR mix (Appendix A) 
 0.25μl Taq enzyme (Fisher Scientific; 5,000u/ml; FB600015) 
 31.75μl nanopure H2O 
 2l of whole cell suspension (in 10mM MgSO4)   
 50l total volume 
Cycling conditions are shown in Table 5. After PCR, samples were analyzed by 
gel electrophoresis.  
 Table 5. Whole colony PCR amplicon sizes   
Strains Primer Pair Fragment Size 
1362, 1364 RK765 x RK1 ~724 
1359, 1360 RK765 x RK1 ~231 
 
Ligations 
Each double digested PCR amplicon was ligated into the double digested pRS415 
reporter vector (see “Preparing the pRS415 vector for cloning”).  A typical ligation 
reaction consisted of the following: 
 50ng of plasmid vector 
 50ng of amplified phage DNA 
 2μl 10X buffer (New England BioLabs #B0202S; 10X stock) 
 Xμl H2O 
 1μl of ligase enzyme (New England BioLabs #M0202S; 400000 u/ml) 
 20μl total volume 
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The concentration of the double digested, purified PCR amplicons was estimated 
from the band intensity on agarose DNA gels. To avoid multiple inserts, a 1:10 dilution 
of the amplicon was typically used. 
Ligations were incubated at 14°C overnight in a PCR machine. After incubation, the 
enzyme was heat inactivated at 65°C for 20 minutes. After heat inactivation, the reactions 
were purified by ultrafiltration using npH2O. Final recovered volume was 20 l. 
Preparation of Electrocompetent Cells  
E. coli MC1000 cells were grown overnight at 37°C in TB broth. The overnight 
culture was diluted 1:100 in 100ml of LB (Appendix A) in a 250ml Erlenmeyer flask. 
The culture was incubated at 37C, 250 rpm until the OD600 reached ~0.5. The culture 
was divided into 2-50ml conical centrifuge tubes and cooled on ice at least 15 minutes. 
After chilling, the samples were centrifuged in a swinging bucket rotor at 2500xg, 15 
minutes, at 4C. The supernatant was removed and the pellets were suspended in 25ml 
each of ice cold 10% glycerol. The sample was centrifuged again and the supernatant was 
discarded. This cell-washing step was repeated once. After the second 25ml wash, the 
cells were pelleted again and suspended in 1.5 of 10% glycerol and transferred to a cold 
1.5ml centrifuge tubes. The cell suspensions were centrifuged at 4°C, 3400xg for 10 
minutes and the supernatants were removed. Each cell pellet was suspended in 300μl of 
10% glycerol. Aliquots  (40l) were transferred to sterile microcentrifuge tubes.  The 
electrocompetent cells were used immediately or stored at -80C. 
For a single tube of electrocompetent cells, a 5ml culture was grown overnight 
and diluted as described above. Once the culture reached an OD600 ~0.5, the culture was 
centrifuged in a swinging bucket rotor at 2500xg, 15 minutes, at 4C. The supernatant 
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was removed and the pellet was resuspended with 5ml of 10% ice-cold glycerol and 
centrifuged again. The supernatant was removed and the pellet was resuspended with 
1.5ml of 10% ice-cold glycerol and transferred to a microcentrifuge tube. The cells were 
centrifuges at 3400xg for 10 minutes.  The supernatant was removed and the pellet was 
resuspended in 40l of ice-cold 10% glycerol. This was used immediately or stored at -
80C. 
Electroporation 
Electrocompetent cells were freshly prepared or thawed on ice immediately prior 
to use.  For electroporation of a purified ligation reaction, an aliquot of cells (40-50ul) 
was mixed with approximately half of the purified ligation products.  This mixture was 
transferred to a pre-chilled electroporation cuvette (2 mm gap; BioExpress; Cat. No. E-
5010-2) and kept on ice.   A Bio-Rad GenePulser Xcell machine was used for all 
electroporation. The electroporation settings were: 2.5 kV, 25 F, 200 Ω. After 
electroporation, 1 of Super Optimal Broth, SOC (Appendix A), was added to the cuvette 
and thoroughly, but gently, mixed. This broth maximizes the efficiency of cell 
transformations. The cell suspension was transferred to a 15ml culture tube (Fisherbrand; 
Cat. No. 05-539-12) and incubated for 1 hour at 37°C with shaking (250rpm). Different 
amounts (0.1ml or 0.15ml) of cells were plated onto prewarmed MacConkey-Lactose–
Ampicillin plates (Appendix A) and incubated at 37°C overnight. A control 
electroporation in which no DNA was added was performed on each new batch of 
electrocompetents cells. These cells were plated on the same selective media and 
incubated under the same conditions as the cells that received ligated plasmid DNA. 
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Purification and culturing of clones 
The desired clones containing amplified DNA from the parental (O276) and 
mutant (O367) phages were selected on MacConkey-Lactose ampicillin plates. If a 
promoter is inserted in the reporter vector, the lac operon will be expressed, causing 
transformants to turn red on the plates. A white colony indicates the uptake of the 
plasmid, but no expression of the lac operon. After the initial selection, candidates were 
colony purified by streaking for isolation on the same type of media. Plates were 
incubated at 37°C overnight. After overnight growth, single colonies were picked and 
transferred to 5ml of TB broth supplemented with ampicillin. The broth cultures were 
incubated overnight at 37°C with shaking at 250 rpm. The next day, the overnight 
cultures were centrifuged at 9500xg at 4C. The supernatant was discarded and the cell 
pellet was suspended in 10mM MgSO4. These cell suspensions were stored in the 
refrigerator. This maintains cell viability while additional tests were performed to verify 
the desired clones. 
Sequencing 
All clones were verified by DNA sequencing.  A typical sequencing reaction 
consisted of the following: 
X l DNA (100ng/μl); Do not exceed 5μl volume 
1μl primer (100pmol/l) 
2μl 5X sequencing buffer 
2μl “Sequencing Juice” (Applied Biosystems BigDye® Terminator v3.1 Cycle 
Sequencing Kit; Part No.: 4336917) 
(5-X)μl nanopure H2O 
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10μl final volume 
Reactions were completed in a PTC-200 Peltier Thermal Cycler using the cycling 
conditions outlined in Table 6. 
Table 6. Sequencing Reaction Cycling Conditions 
 Temperature (C) Time (Minutes) 
Step 1 96 0:30 
Step 2 50 0:15 
Step 3 60 4:0 
Step 4 72 1:00 
Step 5 Go to 1 for 24 times 
Step 6 10 Forever 
Step 7 End 
 
Purification of Sequencing Reactions 
The SigmaSpin Sequencing Reaction Clean-up Kit (Sigma-Aldrich; S5059-70EA) 
was used to remove unincorporated nucleotides and enzyme from the reaction products.  
The purified samples were dried using a CentriVap Concentrator (LABCONCO; Cat. No. 
7810000). The dried material was suspended in 15 ls of formamide before loading onto 
the DNA sequencer. 
Analysis of Sequencing Products 
DNA sequencing reaction products were examined on an ABI 3130 Automated 
Capillary Sequencer.  
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Bioinformatic Analysis 
Geneious® R6 (Biomatters Ltd.; Version 6.1.7) software was used to analyze 
DNA sequences, perform alignments and generate figures. 
β-Galactosidase Assay 
Quantitative β-Gal assays were performed as described in Experiments in 
molecular genetics by Jeffery H. Miller [22]. 
Five ml cultures of the confirmed clones were grown overnight at 37C in TB 
broth. The following day, the cultures were diluted 1:100 in 25ml of LB broth with 
ampicillin in a 125ml Erlenmeyer flask while shaking at 250 rpm. The cultures were 
incubated at 37C until the OD650 reached approximately 0.2. Samples (3-5ml) were then 
taken at an approximate OD650 of 0.4, and again at an approximate OD650 of 0.6, and kept 
on ice until all samples had been collected. [22] 
Five ml cultures of the confirmed clones were grown overnight at 37C in TB 
broth. The following day, the cultures were diluted 1:100 in 25ml of LB broth with 
ampicillin in a 125ml Erlenmeyer flask while shaking at 250 rpm. The cultures were 
incubated at 37C until the OD650 reached approximately 0.2. Samples (3-5ml) were then 
taken at an approximate OD650 of 0.4, and again at an approximate OD650 of 0.6, and kept 
on ice until all samples had been collected. The OD650 gives a standard measure of cell 
density. By taking this value at multiple time points, cell growth can be monitored for the 
exponential phase of cell division. This value also allows for the normalization of enzyme 
readings for that specific density. [22] 
Reactions were started by adding 0.2ml of the substrate O-Nitrophenyl--
galactoside, ONPG (4mg/ml stock solution in water), to each tube and mixed quickly. 
 28 
The time of addition of the substrate was immediately noted and the reaction was closely 
monitored for the appearance of a light yellow color. Reactions were stopped by adding 
0.5ml of 1M Na2CO3 and the time was recorded. The absorbance at 420nm and 550nm 
was measured for each reaction tube. Equation 1 shows how Miller Units of -
Galactosidase activity were calculated. [22] 
                                         (
                
                                     
)  (1) 
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CHAPTER 3 
 
 
RESULTS 
 
 
 This study worked with a parental hybrid phage (O276) whose growth was 
blocked by the rpoCY75N mutation in the ’ subunit of RNA polymerase. We wanted to 
find a mutant phage derivative that could grow on this antitermination defective strain. 
To do this, the phage was mutagenized and forced to grow on the antitermination 
defective host. Plaques formed and phage was harvested from these plaques. A mutant 
phage (O367) was selected and its genome was sequenced, along with the parental strain. 
Comparison of the two sequences revealed a 2-base pair mutation in O367 and we set out 
to characterize this mutation.  
Hybrid phage 
The parental phage used in this study is a hybrid of bacteriophages HK022 and 
Lambda, (phage O276). The hybrid contains the HK022 immunity region with the 
remaining part of the genome originating from Lambda. This phage was generated by 
crossing a Lambda phage mutant carrying the b519 and b515 deletions with an HK022 
prophage that carried a cIts12 P :: Km
R
 mutation [19]. The HK022 genes present in O276 
include nun, cI, cro and cII [19]. Figure 10 shows the parental phage genome. It also 
shows classic Lambda mutations nin and byp for comparison of location relative to the 
orc mutation; however, these mutations (nin and byp) do not occur in the parental or 
mutant phage. 
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Figure 10. Parental phage genome. Terminators are denoted in red. The mutation characterized in this study is 
labeled “orc mutation” for “overcomes rpoC” and is shown between TR3 and TR4. The location of the Lambda 
phage byp mutation is downstream of TR4 and before TR’. The sites of the nin3 and nin5 deletions in the Lambda 
phage are shown. pL, pR, and Pnun promoters are denoted in blue. The putR and putL RNA products are shown 
in purple. The ctsI2 was used as a marker during the construction of the hybrid phage. 
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The parental phage was mutagenized via growth on a mutagenic bacteria strain 
and UV irradiated. Phage was harvested from plaques and forced to grow on the 
antitermination defective host carrying the rpoCY75N mutation. A mutant derivative of 
this hybrid (O367) was recovered from plaques and sequenced.   
Phage Sequence Analysis 
From the genomic sequence, it was determined that the mutation did not occur in 
a gene or in a transcription terminator, meaning this mutation had a different function. 
Analysis of the sequence around the mutation in O367 revealed that it created a potential 
-10 hexamer by changing two sequential bases (T and C at positions 35,702 and 35,703 
in the genome to an A and T respectively) between the TR3 and TR4 terminators in the 
phage genome (Figure 10). Sequence alignment of the mutation with an E.coli promoter 
consensus sequence supported the hypothesis that a new promoter may have been 
created. (Figure 11)  
 
Figure 11. E.coli promoter consensus sequence alignment. Alignment of parental and mutant phage around the 
mutation with the consensus sequence in the 5’ to 3’ direction. The -35 and -10 hexamers are underlined. The original 
sequence in the parental phage is denoted in blue. In the mutant phage, five out of 6 bases match in the -10 region and 3 
out of 6 bases matches in the -35 region, denoted in red [4, 5].  
Additional sequence inspection revealed a possible UP element near the -35 
region [7] (Figure 12). The presence of an UP element may contribute to the strength of 
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the promoter. 
 
Figure 12. UP element alignment. Alignment of UP element sequence with the phage sequence upstream of the -35 
region. This region is homologous in the parental phage. There are 14 matches with the consensus indicated in red. 
Amplification of potential promoter sequences from phage DNA 
To determine if this new mutation resulted in promoter activity, template DNA 
was first amplified using the primer combinations shown in Table 3. Amplified DNA for 
strains RK1362 and RK1364, analogous DNA from the parental and mutant phage 
respectively and also containing the TR4 terminator, were analyzed on a 1.2% agarose 
gel. (Figure 13)  
 
Figure 13. 1.2% Agarose gel of amplified phage DNA from RK1362 and RK1364. Lane 1: Lambda HindIII Ladder. 
Lane 2: 100-bp ladder. Lane 4: amplification from RK1362. Lane 7: amplification from RK1364. Both were expected 
to be 567 base pairs in length. 
Amplified DNA for strains RK1359 and RK1360, analogous DNA from the 
parental and mutant phage respectively without the TR4 terminator, were resolved on a 
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2% gel due to the smaller size of the amplicon. Figure 14 is the gel image of amplifed 
DNA.  
 
Figure 14. 2% Agarose Gel of Amplified phage DNA from RK1359 and RK1360. Lane 1: Lambda HindIII. Lane 2: 
100-bp ladder. Lane 3: RK1359. Lane 6: RK1360. Both were expected to be 74 base pairs in length. 
Following amplification of phage DNA as shown above, the phage DNA was 
digested as described in the materials and methods. It was then purified and ligated into 
digested pRS415 plasmid and prepared for electroporation as described in the materials 
and methods to monitor the expression of the lac operon by the putative promoter on the 
pRS415 plasmid.  
Electroporation Results 
MacConkey-Lactose plates supplemented with ampicillin were used to select for 
the desired recombinants after electroporation. The average colony number recovered 
from each transformation is reported in Table 7. 
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Table 7. Transformants recovered on MacConkey-Lactose-Ampicillin plates 
Strain White Colonies Red Colonies 
RK1359 T.N.C. 0 
RK1360 0 T.N.C. 
RK1362 60 5 
RK1364 T.N.T.C. 40 
*T.N.T.C. is the abbreviation of “too numerous to count”, which signifies colony numbers greater than 300. 
A transformation plate of strain RK1360 is shown in Figure 15 as an example of 
the phenotype of clones that display promoter activity on a MacConkey-Lactose-
Ampicillin plates. 
 
Figure 15. Transformation plate of strain RK1360 exhibiting red colonies indicating promoter activity. 
A transformation plate of strain RK1359 is shown in Figure 16 as an example of 
the white phenotype on a MacConkey-Lactose-Ampicillin plate. 
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Figure 16. Transformation plate of strain RK1359 exhibiting too numerous to count white colonies indicating no 
promoter activity. 
Streak Plate Purification 
Single colony transformants were picked from the transformation plates and 
purified by the streak plate method on MacConkey-Lactose-Ampicillin plates. The 
number selected along with their color after growth are oultined in Table 8. Purified 
colonies from these plates were used to inoculate broth cultures.   
Table 8. Phenotype of colonies selected for purification 
Strain Number Selected for Isolation Phenotype After Growth 
RK1359 8 white All White 
RK1360 8 red All Red 
RK1362 9 red, 7 white All White 
RK1364 8 red, 16 white All Red 
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PCR Confirmation of candidate clones 
After colony purification, single colonies were grown in LB broth media with 
ampicillin. To confirm that cell cultures were transformed with the correct plasmid, 
whole cell PCR was performed with the primer pairs from Table 5.  
PCR products amplified from pRK1362 were resolved on a 2% gel. Three 
cultures were correct as shown in Figure 17. 
 
Figure 17. 2% Agarose Gel of Amplified RK1362 from transformants. Lane 1 is the 100-bp ladder. Lanes 6-8: 
RK1362. The expected size was 724 base pairs.  
PCR products amplified from pRK1364 were resolved on a 2% gel. Five cell 
cultures were correct as shown in Figure 18.   
 
Figure 18. 2% Agarose Gel of Amplified RK1364 from transformants. Lane 1 is 100-bp ladder. Lanes 4-8: RK1364. 
Expected size was 724 base pairs. 
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PCR amplified products from pRK1359 and pRK1360 were imaged on a 2% gel 
due to the small fragment size. Six cell cultures were correct for RK1359 and 8 cell 
cultures were correct for RK1360 as shown in Figure 19.  
 
Figure 19. 2% Agarose Gel of Amplified RK1359 and RK1360 from transformants. Lane 1: 100-bp ladder. Lanes 2, 5-
9: RK1359. Lanes 11-18: RK1360. Expected size was 231 base pairs in length for both. 
Sequencing 
Plasmids were isolated from cultures confirmed by Whole Cell PCR and 
sequenced using the RK1 primer (Table 5).  This analysis confirmed that all the clones 
were correct and no mutations were introduced by the PCR amplificaton process.  Figure 
20 shows alignment of pRK1362 and pRK1364 with emphasis on the cloned region and 
the mutation difference between the two.   
 
Figure 20.  Sequence Alignments of amplified phage DNA. The parental strain is pRK1362A and the mutant strain is 
pRK1364A. The green bar at the top represents homologous sequence alignment. The gap in the green bar reflects the 
differences between the two sequences. The mutation is located upstream of the Lambda TR4 terminator.  
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-Galactosidase Assays 
The pRS415 plasmid contains a promoterless lacZ gene whose expression can be 
assayed to determine the activity of cloned promoter sequences. Quantitative -gal assays 
were performed on cells containing pRK1359, pRK1360, pRK1362, and pRK1364.  
pRK1359 and pRK1360 are  equivalent clones of DNA amplified from the parental and 
mutant  phages respectivley containing only the region with the putative promoter 
element. pRK1362 and pRK1364 are equivalent clones of DNA amplifed from the 
parental and mutant phages respectively and include the region containing the putative 
promoter and the TR4 terminator.  
Strain RK1359 exhibited only 9 Miller Units of activity, which is consistent with 
the idea that this region of the parental phage does not contain a promoter. Strain RK1360 
exhibited 16400 Miller Units of activity, which is consistent with the idea that this region 
contains promoter like sequences. Strain RK1362 exhibited only 65 Miller Units of 
activity, which is consistent with the idea that this region from the parental phage does 
not contain a promoter . Strain RK1364 exhibited 4042 Miller Units of activity, which is 
consistent with the idea that this region from the mutant phage contains the putative 
promoter. The decreased level of activity reflects the activity of the TR4 terminator. Table 
9 shows the assay results.  
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Table 9. Miller Assay Data 
Strain Features Average Miller 
Units 
Standard Error of the 
Mean (+/-) 
1359 No promoter; No terminator 9 1.39 
1360 Putative promoter; No terminator 16400 1889.44 
1362 No promoter; terminator 65 4.75 
1364 Putative promoter; terminator 4042 251.21 
 
This assay also provides a measure of the TR4 terminator’s efficiency by taking 
the ratio of the values obtained for RK1360 and RK1364. This calculation shows that the 
TR4 terminator is 75.4% effective.  
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CHAPTER 4 
 
 
DISCUSSION 
 
 
An E.coli host containing the rpoCY75N mutation in the zinc-binding region of 
the ’-subunit of RNA polymerase blocks antitermination and, therefore, prevents the 
growth of the bacteriophage that use antiterminator RNAs as the mechanism of 
antitermination. A mutant phage was discovered that had the ability to grow on this 
defective E.coli strain, and sequence comparison with the parental strain revealed a two 
base-pair change.  This mutation was named “orc” for “overcomes rpoC”.  
In this study, we have presented evidence that this mutation occurs between two 
terminators, TR3 and TR4, in the hybrid phage and creates a new promoter. -
Galactosidase assays of plasmids with phage DNA inserts showed that the mutant strains 
exhibited significance increases in activity over the wild type strains. This mutation is 
analogous to the byp mutations in the Lambda phage [23].  
Transcription terminators of bacteriophage Lambda  
 The genome of bacteriophage Lambda contains a number of well-characterized 
terminators. These terminators exist to block unwanted phage gene expression, In the λ 
phage, there are at least 4 terminators in the right operon (TR1, TR2, TR3, and TR4) that 
are biologically significant [24].  
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 At PR initiated transcription, transcription continues through the TR1 terminator 
with 50% efficiency due to the N-protein encoded in the PL operon [24]. However, 
transcription halts in the nin-region due to the presence of multiple terminators before 
reaching the gene that encodes for the Q-protein (Figure 21) [24]. TR2 was the first 
terminator to be characterized in the nin region because it shares common features with 
the Rho-independent termination mechanism [24, 25]. 
 The characterization of the TR3 and TR4 terminators occurred via the analysis of a 
Lambda derivative with the roc mutation. The roc region occurs downstream of TR2 and 
is a sub-region of the nin-region and is characterized by a 1900 base deletion [25]. This 
analysis showed that simple point mutations in this region did not lead to an elimination 
of termination in that region, leading to the conclusion that additional terminators existed 
in this region. [24]. Analysis of this region via mutagenesis experiments showed that two 
biologically significant terminators existed, TR3 and TR4, and were found to be Rho 
dependent terminators [24].  
Similarities to Lambda Phage 
There are two types of mutations that occur in Lambda that allows for different 
degrees of N-independent gene expression: the nin5 deletion and the byp mutation. The 
nin5 mutation is a deletion that removes 2,805 base pairs, which includes the TR2 and 
TR3 terminators (Figure 21) [23, 24]. This deletion removes the need for the N protein 
and Nus host factors. This is called N-independence [23, 24].   
The byp mutation, characterized in the early 1970s [26, 27], creates a new 
promoter that drives the expression of the Q protein. Consequently, Q can be transcribed 
independently of the antitermination in the PR operon (Figure 21) [23]. However, this 
 
42 
only confers partial N-independence. [24] In Lambda, the byp mutation occurs after the 
TR2 and TR3 terminators [23]. The orc mutation in the hybrid phage O367 creates a -10 
hexamer similar to the Lambda byp mutation. The orc mutation occurs after TR3 but 
before TR4. Therefore, orc and byp occur at different locations in the genome.  
 
Figure 21. Classic Lambda Mutations. This image shows the critical region of the hybrid phage genome with the 
classic nin and byp Lambda mutations in relation to the position of our orc mutation. The transcription terminators are 
denoted in red. The Lambda byp mutation is shown downstream of TR4, but before the Q gene for the Q protein. The 
nin deletions are shown in relation to the transcription terminators that are removed [28]. 
Broader Implications 
 In our study of gene expression, the phage has served as a model system in an 
attempt to gain knowledge that is applicable to other fields. In the study of mammalian 
viruses, the human immunodeficiency virus, HIV, is one of the viruses at the forefront of 
research. The expression of HIV genes has been found to behave in a similar way to that 
of bacteriophage antitermination [29].  
 In HIV, a tat gene exists, which encodes for a protein named Tat. This protein 
binds at a trans-activating region (TAR) site in the RNA transcript to form a stable stem-
loop RNA structure. This structure interacts with RNA polymerase II with the assistance 
of several co-factor proteins to accelerate the polymerase and to lead to the expression of 
HIV genes [29]. The Tat RNA-binding protein is similar to the Lambda RNA-binding 
protein N. Tat utilizes co-factor proteins to interact with RNA polymerase II to allow for 
HIV gene expression; whereas Lambda N interacts with host Nus factors to bind to RNA 
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polymerase to antiterminate and allow for phage gene expression. By understanding 
bacteriophage gene expression and the model system bacteriophage can be, the HIV Tat-
TAR interaction could be more closely studied to allow for a greater understanding of 
HIV gene expression. 
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CHAPTER 5 
 
 
CONCLUSION 
 
 
 The two-base pair orc mutation that is found between TR3 and TR4 of the mutant 
phage creates a promoter that allows for phage growth on the antitermination defective 
E.coli. Qualitatively, we showed that the putative promoter in the mutated phage 
functions to express the lacZ gene in the promoter probe vector, while the comparable 
region in the parental phage does not express the lacZ gene. This was demonstrated by 
the phenotypes exhibited by the respective strains on the MacConkey-Lactose-ampicillin 
plates. In quantitative -Galactosidase assays, the putative promoter exhibited 
significantly higher levels of activity over the comparable parental phage DNA region, in 
the presence or absence of the terminator sequence. A reduction in lacZ gene expression 
was observed in the -Galactosidase assays between RK1360 and RK1364. This 
reduction was expected because of the activity of the terminator. However, the activity of 
the single terminator is not sufficient to prevent growth of the phage. Approximately 25% 
of the transcripts originating from the new promoter read through the TR4 terminator.
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CHAPTER 6 
 
 
RECOMMENDATIONS 
 
 
A detailed analysis of the possible UP element sequence could be performed to 
determine if it increases RNA polymerase recognition at the promoter and, therefore, 
increases the promoter’s strength. The sequence has 14 matches to the UP element 
consensus sequence and could possibly serve as an UP element.  
A second study could be performed to analyze the changes in mutant phage 
growth if it was grown on the rpoCY75N mutant host that was further mutated to also be 
Rho deficient. A previous study suggests that N-meditated antitermination is not required 
for Q expression if the host bacterium has reduced Rho production because termination at 
TR3 and TR4 is prevented [21]. The absence of Rho dependent termination may allow for 
better phage growth on the rpoCY75N host bacterium, possibly leading to the formation 
of larger plaques. This would support the idea that terminators are efficient at restricting 
gene expression unless they are suppressed or bypassed. This study could be extended to 
the parental phage to determine if the growth of the parental phage could be restored 
based on the appearance of plaques on the mutant host.
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APPENDIX 
 
 
The recipes for the types of media used in this lab are as follows: Luria Broth 
(LB), Lennox recipe: NaCl (Fisher BioReagents; BP358-212) 5g, Yeast Extract (BD; 
212750) 5g, Tryptone (Fisher BioReagents; BP9726-500) 10g, per liter in diH2O. Aliquot 
100ml to 125ml screw cap bottle then autoclave. Terrific Broth (TB): Bacto-Tryptone 
(BD; 211705) 10g, NaCl (Fisher BioReagents; BP358-212) 5g, adjust pH to 7.4 with 5N 
NaOH (Sigma-Aldrich; 221465-500G) per liter. Aliquot 100ml to 125ml screw cap 
bottles then autoclave. Super Optimal Broth (SOC): Tryptone (Fisher BioReagents; 
BP9726-500) 20g, Yeast Extract (BD; 212750) 5g, NaCl (Fisher BioReagents; BP358-
212) 0.5g, 2M KCl (Acros; CAS: 744-40-7) 1.25ml, 1M MgCl2 (Fisher Chemical; M-
13448) 10ml per liter. Aliquot 100ml to 125ml screw cap bottles then autoclave. Cool 
then add 1ml 1M MgSO4 (Sigma; M-2773) and 2ml glucose (Fisher Scientific; D16500). 
MacConkey-Lactose Plates with Ampicillin: Difco MacConkey Agar (Difco; 281810) 
50.0g per liter. Autoclave then cool before adding 100g/ml of Ampicillin (Fisher 
BioReagents; BP-1760-25). Pour into petri plates (USA Scientific; 100x15mm; 8609-
0010). 
 The recipe for the PCR mix used in this protocol is as follows: 6l of 10mM 
dATP, 6l of 10mM dGTP, 6l of 10mM dCTP, 6l of 10mM dTTP, 330l of 10X 
Buffer A (Fisher Scientific Kit; FB-6000-10). 316l of nanopure H2O. Mix in a 1.5 
microcentrifuge tube and keep on ice if used immediately or store at -20C. 
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 The recipe for the TAE buffer used is as follows: 50X TAE: Tris-base (Fisher 
BioReagents; M-11645) 242g, Glacial Acetic Acid (Amresco; 0714-4L) 57.1ml, 0.5M 
EDTA (Sigma; E-5134) 100ml. Dilute with diH2O to 1 liter. Aliquot 20ml to a 1-L screw 
cap bottle and fill to 1-L line to make 1X TAE. Store at room temperature. 
 The recipe for the loading dye used in this lab is as follows: Mix 0.25% 
bromophenol blue (Sigma-Aldrich; CAS: 115-39-9), 0.25% xylene cyanol FF (Research 
Organics; 7113X), and 30% glycerol (Fisher Chemical; CAS: 56-81-5)in a 15-ml tube. 
Aliquot 500l to a 1.5µl centrifuge tube. Store at room temperature.  
 The recipes for the solutions used in the -Galactosidase assay are as follows: Z-
Buffer: 60 mM Na2HPO4 * 7H2O (Sigma-Aldrich; 7782-85-6) 16.1g, 40 mM NaH2PO4 * 
H2O (Sigma-Aldrich; 10049-21-5) 5.5g, 10mM KCl (Acros; CAS: 744-40-7) 0.75g, 1 
mM MgSO4 * 7H2O (Sigma-Aldrich; 10034-99-8) 0.246g, 50 mM -mercaptoethanol 
(Sigma-Aldrich; M-3148) 2.7ml. Do not autoclave. Adjust pH to 7.0. Store in 
refrigerator. 10% SDS: Mix 1g SDS (Sigma-Aldrich; L6026) in 10ml. Equilibrate in 
55C water bath to facilitate dissolving. Dilute 1ml into 9ml of nanopure H2O to create a 
0.1% solution. 
 
